Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHA:688179)
China
· Delayed Price · Currency is CNY 16.70
+0.24 (1.46%)
At close: Apr 21, 2025, 2:57 PM CST
SHA:688179 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 542.3 | 396.72 | 371.02 | 281.25 | 228.19 | Upgrade
|
| Other Revenue | - | 6.16 | 7.08 | 6.41 | 6.03 | Upgrade
|
| Revenue | 542.3 | 402.88 | 378.1 | 287.66 | 234.22 | Upgrade
|
| Revenue Growth (YoY) | 34.61% | 6.55% | 31.44% | 22.82% | 11.74% | Upgrade
|
| Cost of Revenue | - | 162.54 | 156.28 | 110.11 | 93.95 | Upgrade
|
| Gross Profit | 542.3 | 240.33 | 221.82 | 177.55 | 140.27 | Upgrade
|
| Selling, General & Admin | - | 96.08 | 83.96 | 61.35 | 43.86 | Upgrade
|
| Research & Development | - | 51.07 | 38.7 | 22.32 | 15.68 | Upgrade
|
| Other Operating Expenses | 411.85 | 0.78 | 3.22 | 1.52 | 1.6 | Upgrade
|
| Operating Expenses | 411.85 | 148.09 | 127.2 | 85.52 | 61.21 | Upgrade
|
| Operating Income | 130.45 | 92.25 | 94.63 | 92.03 | 79.06 | Upgrade
|
| Interest Expense | - | -6.69 | -4.67 | -0.41 | -0.24 | Upgrade
|
| Interest & Investment Income | - | 6.89 | 8.28 | 10.16 | 1.45 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.11 | 0.4 | -0.11 | -0.24 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.59 | -0.42 | -0.69 | -0.4 | -0.42 | Upgrade
|
| EBT Excluding Unusual Items | 129.86 | 92.14 | 97.95 | 101.27 | 79.6 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 1.46 | 1.3 | 0.35 | 0.77 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.13 | 0.19 | -1.47 | -0.06 | Upgrade
|
| Legal Settlements | - | - | - | - | -0.04 | Upgrade
|
| Other Unusual Items | - | 1.44 | 6.24 | 1.56 | 6.09 | Upgrade
|
| Pretax Income | 129.86 | 94.91 | 105.67 | 101.71 | 86.37 | Upgrade
|
| Income Tax Expense | 30.83 | 9.08 | 12.9 | 12.35 | 11.94 | Upgrade
|
| Net Income | 99.03 | 85.83 | 92.77 | 89.36 | 74.43 | Upgrade
|
| Net Income to Common | 99.03 | 85.83 | 92.77 | 89.36 | 74.43 | Upgrade
|
| Net Income Growth | 15.38% | -7.48% | 3.82% | 20.06% | 16.86% | Upgrade
|
| Shares Outstanding (Basic) | 275 | 245 | 282 | 275 | 220 | Upgrade
|
| Shares Outstanding (Diluted) | 275 | 250 | 289 | 275 | 220 | Upgrade
|
| Shares Change (YoY) | 9.90% | -13.29% | 4.79% | 25.42% | 5.55% | Upgrade
|
| EPS (Basic) | 0.36 | 0.35 | 0.33 | 0.32 | 0.34 | Upgrade
|
| EPS (Diluted) | 0.36 | 0.34 | 0.32 | 0.32 | 0.34 | Upgrade
|
| EPS Growth | 4.99% | 6.69% | -0.92% | -4.28% | 10.71% | Upgrade
|
| Free Cash Flow | - | 10.11 | -105.23 | -98.38 | 72.29 | Upgrade
|
| Free Cash Flow Per Share | - | 0.04 | -0.36 | -0.36 | 0.33 | Upgrade
|
| Dividend Per Share | - | 0.214 | 0.128 | 0.146 | 0.182 | Upgrade
|
| Dividend Growth | - | 67.95% | -12.48% | -19.98% | -9.08% | Upgrade
|
| Gross Margin | 100.00% | 59.65% | 58.67% | 61.72% | 59.89% | Upgrade
|
| Operating Margin | 24.05% | 22.90% | 25.03% | 31.99% | 33.75% | Upgrade
|
| Profit Margin | 18.26% | 21.30% | 24.54% | 31.06% | 31.78% | Upgrade
|
| Free Cash Flow Margin | - | 2.51% | -27.83% | -34.20% | 30.86% | Upgrade
|
| EBITDA | 145.91 | 107.7 | 107.33 | 101.74 | 87.16 | Upgrade
|
| EBITDA Margin | 26.91% | 26.73% | 28.38% | 35.37% | 37.21% | Upgrade
|
| D&A For EBITDA | 15.46 | 15.46 | 12.7 | 9.72 | 8.11 | Upgrade
|
| EBIT | 130.45 | 92.25 | 94.63 | 92.03 | 79.06 | Upgrade
|
| EBIT Margin | 24.05% | 22.90% | 25.03% | 31.99% | 33.75% | Upgrade
|
| Effective Tax Rate | 23.74% | 9.56% | 12.21% | 12.14% | 13.82% | Upgrade
|
| Revenue as Reported | - | 402.88 | 378.1 | 287.66 | 234.22 | Upgrade
|
| Advertising Expenses | - | 5.46 | 3.9 | 3.34 | 2.42 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.